Search results
Parathyroid hormone treatment helps slow development of osteoporosis, researchers find
Medical Xpress· 23 hours agoThe team, led by Marjolein van der Meulen, the James M. and Marsha McCormick Director of the Meinig...
Amgen Is 'Very Encouraged' With Its Obesity Drug. But Can It Take On Novo, Lilly Duopoly?
Investor's Business Daily· 4 days agoManagement said AMG 786 didn't meet the bar for further development, especially compared to the...
How Does Topirmate for Weight Loss Work?
MediaFeed via AOL· 1 day agoIn addition, topiramate itself can cause metabolic acidosis, and this affects what other drugs you can take. Metformin — the diabetes drug sometimes used...
This Gave Me Osteoporosis At 32 & Here's What I Wish People Knew
MindBodyGreen· 3 days agoWhile some health issues are visible to the outside world, many people face chronic conditions that...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 hours agoCrescent Innovations Offers Breakthrough Osteogenic Treatment Technology for Sale, and its impact on Bone Growth and Orthopedics PR Newswire WESTFORD, Mass., May 7, 2024 WESTFORD ...
Big Pharma Has Captured Osteoporosis
Mercola· 4 days agoThe sales funnel concept is crucial to understanding the modern medical industry. The second funnel involves framing preventative medicine as screening individuals for potential health risks ...
Neurocrine Biosciences to Present Phase 3 Baseline Characteristics Data from the CAHtalyst™ Program...
CW39 NewsFix· 2 hours agoNeurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present key information from its neuroendocrinology pipeline, including baseline characteristics data from its CAHtalyst ...
Amgen Is 'Very Encouraged' With Its Obesity Study; Shares Rocket 13%
Investor's Business Daily· 5 days agoThis puts Amgen on track to potentially rival blockbuster weight-loss drugs from Eli Lilly (LLY) and Novo Nordisk (NVO). In addition to the MariTide update, Amgen says it wrapped a Phase 1 study ...
The Women's Health Initiative Trials: Clinical Messages
Medscape· 1 day agoDr JoAnn Manson summarizes the key clinical implications of the WHI trials in three areas: hormone...
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
Benzinga via Yahoo Finance· 7 days agoGeneric and biosimilar manufacturer Sandoz AG (OTC:SDZNY) (OTC:SDZXF) reached an agreement on...
